FDA Approved: BORUZU — Original Application (Amneal Pharmaceuticals LLC)

View source ↗

Summary

FDA approved BORUZU (bortezomib) from Amneal Pharmaceuticals as an original NDA. The approval covers indications including multiple myeloma and mantle cell lymp…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Mantle Cell Lymphoma
• Multiple Myeloma

Drugs mentioned

• BORUZU (BORTEZOMIB)

Snippet

ORIG AP for BORUZU (BORTEZOMIB)